Drug toxicity: Drug–Drug Interaction

Drugs can alter GI absorption by changing stomach pH or competing for absorption sites. Famotidine increases gut pH, reducing absorption of basic drugs like ketoconazole. Cholestyramine decreases propranolol levels by binding it in the intestines. These absorption interactions compromise drug bioavailability and treatment efficacy.

When drugs like aspirin and warfarin are overdosed, they saturate plasma proteins, displacing each other and increasing free drug concentrations. Elevated free drug levels enhance toxicity risk because only unbound drug can exert pharmacological effects. This protein binding interaction is a major mechanism of drug-drug toxicity.

Drugs can induce or inhibit hepatic cytochrome P450 enzymes, altering metabolism of other drugs. Chronic ethanol intake induces CYP2E1, accelerating acetaminophen conversion to toxic NAPQI, causing liver damage. These metabolic interactions change drug clearance rates and can precipitate toxicity through bioactivation and tissue toxicity.

Yes, synergistic drug combinations can enhance efficacy. Glipizide increases insulin secretion while metformin reduces hepatic glucose production; together they effectively regulate blood sugar in diabetes. However, combining aspirin and heparin increases bleeding risk through additive anticoagulant effects, demonstrating that therapeutic action interactions can be beneficial or harmful.

Drug interactions occur through absorption, protein binding, metabolism, and receptor binding pathways. Additive interactions sum effects, synergistic interactions exceed the sum, and antagonistic interactions counteract each other. Functional antagonism involves opposite physiological effects, while chemical antagonism involves direct drug neutralization or dispositional antagonism that reduces drug concentration at target sites.

One drug can block or enhance another's effect at receptor sites, either mitigating or amplifying pharmacological outcomes. Buprenorphine modulates opiate receptor activity and can affect use of other narcotics. These receptor binding interactions alter the intended therapeutic effects and may lead to adverse outcomes when drugs compete for the same binding sites.

Drug-drug interactions alter pharmacokinetic and pharmacodynamic properties, increasing active drug concentration, interfering with metabolism, or disrupting therapeutic effects. Multiple drugs, over-the-counter medications, and supplements can compromise treatment efficacy and cause toxicity. Understanding these interactions helps clinicians predict adverse outcomes and adjust dosing or drug selection to prevent pharmaceutical poisoning potential scenarios.